Compare · COLM vs SILO
COLM vs SILO
Side-by-side comparison of Columbia Sportswear Company (COLM) and Silo Pharma Inc. (SILO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COLM and SILO operate in Apparel (Consumer Discretionary), so they compete in similar markets.
- COLM is the larger of the two at $3.11B, about 1363.3x SILO ($2.3M).
- Both names hit the wire about 3 times in the past 4 weeks.
- COLM has more recent analyst coverage (17 ratings vs 0 for SILO).
- Company
- Columbia Sportswear Company
- Silo Pharma Inc.
- Price
- -
- -
- Market cap
- $3.11B
- $2.3M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Apparel
- Apparel
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1998
- News (4w)
- 3
- 3
- Recent ratings
- 17
- 0
Columbia Sportswear Company
Columbia Sportswear Company, together with its subsidiaries, designs, sources, markets, and distributes outdoor, active, and everyday lifestyle apparel, footwear, accessories, and equipment in the United States, Latin America, the Asia Pacific, Europe, the Middle East, Africa, and Canada. The company provides apparel, accessories, and equipment that are used in various activities, such as skiing, snowboarding, hiking, climbing, mountaineering, camping, hunting, fishing, trail running, water sports, yoga, golf, and adventure travel. It also offers footwear products that include lightweight hiking boots, trail running shoes, rugged cold weather boots for activities on snow and ice, sandals and shoes for use in water activities, and function-first fashion footwear and casual shoes for everyday use. The company sells its products under the Columbia, Mountain Hard Wear, SOREL, and prAna brand names through the company owned network of branded and outlet retail stores, brand-specific e-commerce sites, and concession-based arrangements with third-parties at branded outlet and shop-in-shop retail locations, as well as through independently operated specialty outdoor and sporting goods stores, sporting goods chains, department store chains, Internet retailers, and international distributors. As of December 31, 2020, it operated approximately 450 retail stores. The company was founded in 1938 and is headquartered in Portland, Oregon.
Latest COLM
- Columbia Sportswear Company to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026
- SEC Form SCHEDULE 13G filed by Columbia Sportswear Company
- SEC Form 4 filed by Columbia Sportswear Company
- Peter Rauch Named President of Mountain Hardwear
- EVP, CAO, Gen. Counsel Luther Richelle T converted options into 1,468 shares and covered exercise/tax liability with 478 shares, increasing direct ownership by 6% to 18,219 units (SEC Form 4) (tax liability)
- EVP, COO Kulok Lisa converted options into 1,316 shares and covered exercise/tax liability with 458 shares, increasing direct ownership by 12% to 8,180 units (SEC Form 4) (for withholding tax)
- President Bragdon Peter J converted options into 2,544 shares and covered exercise/tax liability with 827 shares, increasing direct ownership by 6% to 28,846 units (SEC Form 4) (for tax liability)
- Chairman and CEO Boyle Timothy P gifted 1,756 shares, decreasing direct ownership by 0.02% to 9,875,315 units (SEC Form 4)
- SEC Form 10-Q filed by Columbia Sportswear Company
- EVP, COO Kulok Lisa converted options into 319 shares and covered exercise/tax liability with 115 shares, increasing direct ownership by 3% to 7,322 units (SEC Form 4) (for tax liability)
Latest SILO
- SEC Form 8-K filed by Silo Pharma Inc.
- Silo Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- Silo Pharma’s QwikAgents Expands AI Agent Platform with NVIDIA Model Support and New Runtime Flexibility
- Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio
- Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum
- Silo Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
- Silo Pharma Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 10-Q filed by Silo Pharma Inc.
- Silo Pharma Granted European Patent Covering Novel PTSD Therapy